Você procurou por: glukoositason (Finlandês - Inglês)

glukoositason lukitus
glucose clamp technique

keskimääräinen paastoveren glukoositason pienenemä1
reduction of the mean fasting blood

valmisteen ei uskota vaikuttavan veren glukoositason määritykseen.
interferences with determination of blood glucose levels are not expected.

suositukset potilaan glukoositason, rasvojen ja painon seurannasta.
recommendations for monitoring of patients for glucose, lipids, and weight

plasman glukoositason nousu (ks kohta 2 alempana) .
elevated glucose levels (see note 2 below) .

plasman glukoositason nousu (ks. kohta 2 alempana) .
somnolence.common (1-10%):

2) suositukset potilaan glukoositason, rasvojen ja painon seurannasta
1) description of post injection syndrome – education about the 2 intramuscular formulations of olanzapine, including packaging differences – description of reconstitution and proper administration technique – recommendation for a 3-hour on-site observation period post injection – recommendation that prior to giving the injection, the hcp should determine that the patient will not travel alone to their destination – recommendation for informing patients that for the remainder of the day of the injection, they should not drive or operate machinery, should be vigilant for signs and symptoms of a post injection syndrome event, and should be able to obtain assistance if needed – description of the most common symptoms reported with olanzapine overdose that represent the clinical manifestation in post injection syndrome events – recommendation for appropriate monitoring until the event resolves if an event should occur 2) recommendations for monitoring of patients for glucose, lipids, and weight. – promote awareness of appropriate metabolic monitoring by distributing utilized published antipsychotic guidelines.

tämä auttaa veren glukoositason hallinnassa ja lieventää diabeteksen oireita ja komplikaatioita.
this helps to control the level of blood glucose, reducing the symptoms and complications of diabetes.

plasman glukoositason nousu (ks. kohta 1 alempana) .plasman triglyseriditason ja kolesterolitason nousu.
increased appetite.elevated glucose levels (see note 1 below) .

reproduction is authorised provided the source is acknowledged. inkretiinihormonipitoisuutta veressä vildagliptiini saa haiman tuottamaan enemmän insuliinia veren glukoositason ollessa korkea.
reproduction is authorised provided the source is acknowledged. levels of incretin hormones in the blood, vildagliptin stimulates the pancreas to produce more insulin when blood glucose levels are high.

tarvittaessa liprolog voidaan antaa myös laskimoon, esimerkiksi veren glukoositason hallintaan ketoasidoosissa, akuuteissa sairauksissa tai leikkauksen aikana ja sen jälkeen.
if necessary, liprolog may also be administered intravenously, for example; for the control of blood glucose levels during ketoacidosis, acute illnesses or during intra and post operative periods.

glustin 15 mg tabletit auttavat veresi glukoositason säätelyssä, kun sinulla on tyypin 2 diabetes.glustin auttaa elimistöäsi käyttämään paremmin tuottamaansa insuliinia.
glustin 15 mg tablets helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces.

keskimääräinen verenglukoosin pienenemä 2 t. aterian jälkeen 1 (aamu ja ilta) keskimääräinen paastoveren glukoositason pienenemä1 hypoglykemian ilmaantuvuus tutkimuksen lopussa painon nousu2
reduction of the mean of combined morning/evening two-hour postprandial 1 blood glucose reduction of the mean fasting blood 1 glucose incidence of hypoglycaemia at endpoint bodyweight gain2 1 from baseline to end of liprolog mix25 treatment 2 in patients randomised to liprolog mix25 during 5.2 pharmacokinetic properties

vildagliptiini parantaa myös alfasolujen herkkyyttä glukoosille suurentamalla endogeenisen glp-1:n pitoisuutta, mikä johtaa glukoositason kannalta tarkoituksenmukaisempaan glukagonin eritykseen.
by increasing endogenous glp-1 levels, vildagliptin also enhances the sensitivity of alpha cells to glucose, resulting in more glucose-appropriate glucagon secretion.